Metformin hydrochloride is not usually used as a weight loss drug, but may have an auxiliary weight loss effect on some obese patients with diabetes. Metformin hydrochloride is a first-line drug for the treatment of type 2 diabetes, which plays a role mainly by improving insulin resistance and inhibiting hepatic glucose output. The weight loss effect varies from person to person and should be strictly used according to medical advice. The weight loss mechanism of metformin hydrochloride may be related to the following factors: inhibiting appetite center to reduce calorie intake, improving insulin sensitivity to reduce fat synthesis, regulating intestinal microbiota to affect energy metabolism. Clinical observations have shown that some patients may experience moderate weight loss after 3-6 months of standardized medication, with limited average weight loss. This effect is relatively significant in obese individuals with insulin resistance, but not significant in those with simple obesity. Attention should be paid to the possibility of gastrointestinal reactions such as nausea and diarrhea caused by medication. Long term use requires monitoring of vitamin B12 levels.

There are clear restrictions on the use of metformin hydrochloride for weight loss: the use of metformin hydrochloride in non diabetes patients may disrupt normal glucose metabolism, and sudden withdrawal of the drug may lead to rebound weight gain. Teenagers, pregnant women, and individuals with liver and kidney dysfunction are prohibited from using it. At present, neither domestic nor foreign guidelines have approved it as a weight loss indication, and the risks of using drugs beyond the instructions need to be fully evaluated. Healthy weight loss should still be based on diet control and exercise, and if necessary, approved weight loss drugs such as orlistat can be combined under the guidance of a doctor.

It is recommended that individuals with weight loss needs prioritize lifestyle interventions such as 30 minutes of aerobic exercise per day, reducing intake of refined carbohydrates, and ensuring 7 hours of sleep to control their weight. If you have metabolic diseases such as diabetes and polycystic ovary syndrome, you should go to the endocrine department to complete the insulin release test and other examinations, and the specialist should develop a personalized treatment plan. Self medication of metformin hydrochloride may lead to adverse reactions such as hypoglycemia and cannot replace regular weight loss treatment.

Comments (0)
Leave a Comment
No comments yet
Be the first to share your thoughts!